Novel alleles of the chemokine-receptor gene CCR5

American Journal of Human Genetics

Volumn 61, Issue 6, 1997, Pages 1261-1267

  Carrington, Mary ^a,b   Kissner, Teri ^a   Gerrard, Bernard ^a   Ivanov, Sergey ^a   O'Brien, Stephen J ^b   Dean, Michael ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; DNA; TRINUCLEOTIDE;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEGRO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031455968     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301645     Document Type: Article

References (28)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958
2. Ansari-Lari MA, Liu X-M, Metzker ML, Rut AR, Gibbs RA (1997) The extent of genetic variation in the CCR5 gene. Nat Genet 16:221-222
3. Atchison RE, Gosling J, Mionteclaro FS, Franci C, Digilio L, Charo IF, Goldsmith MA (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924-1926
4. Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T (1997) HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 3:252-253
5. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, et al (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148
6. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM (1996) Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1-α, MIP-1-β, and RANTES. J Leukoc Biol 60:147-152
7. Connor RI, Ho DD (1994) Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 68:4400-4408
8. Cullen M, Noble J, Erlich H, Thorpe K, Beck S, Klitz W, Trowsdale J, et al (1997) Characterization of recombination in the HLA class II region. Am J Hum Genet 60:397-407
9. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, et al (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862
10. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, et al (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666
11. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, et al (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149-1158
12. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673
13. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, et al (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2:1240-1243
14. Li WH (1997) Molecular evolution. Sinauer, Sunderland, MA
15. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, et al (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377
16. Martinson JJ, Chapman NH, Rees DC, Liu Y-T, Clegg JB (1997) Global distribution of the CCR5 gene Δ32-basepair deletion. Nat Genet 16:100-103
17. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW (1997) The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 3:338-340
18. Murphy PM (1996) Chemokine receptors: structure, function, and role in microbial pathogenesis. Cytokine Growth Factor Rev 7:47-64
19. O'Brien TR, Winkler C, Dean M, Nelson JAE, Carrington M, Michael NL, White GC II (1997) HIV-1 infection in a man homozygous for CCR5-Δ 32. Lancet 349:1219
20. Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174-1178
21. Roos MTL, Lange JMA, de Goede REY, Coutinho RA, Schellekens PTA, Miedema F, Tersmette M (1992) Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 165:427-432
22. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, et al (1996) Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-446
23. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996a) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35: 3362-3367
24. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, et al (1996b) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725
25. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, deGoede REY, van Steenwijk RP, Lange JMA, et al (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 66:1354-1360
26. Smith MW, Dean M, Carrington M, Winkler C, Huttley G, Lomb DA, Goedert J, et al (1997) Contrasting genetic influence of CCR2 and CCR5 receptor gene variants on HIV-1 infection and disease progression. Science 277:959-965
27. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, Seroco Study Group (1997) HIV-1 infection in an individual homozygous for CCR5-Δ32. Lancet 349: 1219-1220
28. Zimmerman PA, Bucklerwhite A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, et al (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 3:23-26